Buyout firm CVC is grabbing International Flavors & Fragrances’ food-ingredients unit for $4.3 billion. Ingredion is chasing Britain’s Tate & Lyle. Unilever is dropping $270 million on a New Haven research lab. The boring, delicious world of food ingredients is suddenly the hottest table in M&A.

Buyout giant CVC Capital Partners agreed to buy the food-ingredients business of International Flavors & Fragrances (IFF) in a deal valuing the division at $4.3 billion including debt. IFF — which makes everything from perfume scents to the emulsifiers and sweeteners that make food production more efficient — is keeping a 10% stake so it can ride any upside under CVC’s ownership.
It’s the latest move in IFF’s long campaign to slim down and boost profitability after a debt-heavy 2021 merger with DuPont’s nutrition business. CVC, which oversees about $243 billion, expects to close by the middle of next year.
The timing isn’t a coincidence. Rival Ingredion (INGR) is in talks to buy U.K. ingredients maker Tate & Lyle, having recently floated a takeover proposal worth about $3.7 billion. And Unilever (UL) — mid-transformation into a beauty and wellness company — is investing $270 million in a new innovation center in New Haven, Connecticut, its biggest U.S. R&D infrastructure investment in 40 years. “The U.S. is very much the center of gravity for Unilever,” its USA president said.
When private equity, strategic buyers, and corporate R&D budgets all pile into the same unglamorous corner of the economy at once, that’s a signal: smart money sees durable, defensive cash flows. People keep eating in good times and bad — recession or melt-up, the sweetener still has to come from somewhere.
We like this corner for a reason that never goes out of style: boring, defensive cash flows are a feature, not a bug. Food ingredients is a pick-and-shovel business — it sells to every food company regardless of which brand is winning — and it’s exactly the kind of steady compounder that anchors a portfolio when the exciting stuff gets wobbly.
We’re adding Ingredion (INGR) to the watch-and-buy list as a consolidator in a sector private equity is actively bidding up. The principle: diversify across the boring and the brilliant. A book that’s all AI and energy is a thrill ride; a little exposure to the companies that flavor the world’s food is the seatbelt. And in a year when even a $4.3 billion deal barely makes the front page, the consistent winners are the banks and advisers collecting fees on all of it.
Bring this article and your statement. We translate every WSJ story into a position-level decision in your account.
Book Q2 Review →View Portfolios →Saturday note + intraday alerts on portfolio moves. WSJ-driven analysis, no spam.
We'll also ask permission to send browser push alerts. Unsubscribe anytime.
Get every commentary in your inbox.
Free. One email per market day. Unsubscribe anytime.